Salicylate Regulates Cyclooxygenase-2 Expression through ERK and Subsequent $NF-_kB$ Activation in Osteoblasts

  • Chae, Han-Jung (Department of Pharmacology and institute of Cardiovascular Research, School of Medicine, Chonbuk National, University) ;
  • Lee, Jun-Ki (Department of Dental Pharmacology and Wonkwng Biomaterial implant Research Institute, School of Dentistry, Wonkwang University) ;
  • Byun, Joung-Ouk (Department of Dental Pharmacology and Wonkwng Biomaterial implant Research Institute, School of Dentistry, Wonkwang University) ;
  • Chae, Soo-Wan (Department of Pharmacology and institute of Cardiovascular Research, School of Medicine, Chonbuk National, University) ;
  • Kim, Hyung-Ryong (Department of Dental Pharmacology and Wonkwng Biomaterial implant Research Institute, School of Dentistry, Wonkwang University)
  • Published : 2003.08.21

Abstract

The expression of cyclooxygenase-2 (COX-2) is a characteristic response to inflammation and can be inhibited with sodium salicylate. $TNF-{\alpha}$ plus $IFN-{\gamma}$ can induce extracellular signal-regulated kinase (ERK), IKK, $I{\kappa}B$ degradation and NF-${\kappa}B$ activation. The inhibition of the ERK pathway with selective inhibitor, PD098059, blocked cytokine-induced COX-2 expression and $PGE_2$ release. Salicylate treatment inhibited COX-2 expression induced by $TNF-{\alpha}$/$IFN-{\gamma}$ and regulated the activation of ERK, IKK and $I{\kappa}B$ degradation and subsequent NF-${\kappa}B$ activation in MC3T3E1 osteoblasts. Furthermore, antioxidants such as catalase, N-acetyl-cysteine or reduced glutathione attenuated COX-2 expression in combined cytokines-treated cells, and also inhibited the activation of ERK, IKK and NF-${\kappa}B$ in MC3T3E1 osteoblasts. In addition, $TNF-{\alpha}$/$IFN-{\gamma}$ stimulated ROS release in the osteoblasts. However, salicylate had no obvious effect on ROS release in DCFDA assay. The results showed that salicylate inhibited the activation of ERK and IKK, $I{\kappa}B$ degradation and NF-${\kappa}B$ activation independent of ROS release and suggested that salicylate exerts its anti-inflammatory action in part through inhibition of ERK, IKK, $I{\kappa}B$, $NF-{\kappa}B$ and resultant COX-2 expression pathway.

Keywords

References

  1. Abate A, Oberle S, Schroder H. Lipopolysaccharide-induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-kappa B translocation. Prostaglandins Other Lpid Mediat 56: 277-290, 1998 https://doi.org/10.1016/S0090-6980(98)00061-6
  2. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066 -1071, 1997 https://doi.org/10.1056/NEJM199704103361506
  3. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 6-12; 319(6053): 516-518, 1986 https://doi.org/10.1038/319516a0
  4. Chae HJ, Chae SW, Chin HY, Bang BG, Cho SB, Han KS, Kim SC, Tae KC, Lee K H, Kim DE, Im MK, Lee SJ, Chang JY, Lee YM, Kim HM, Kim HH, Lee ZH, Kim HR. The p38 mitogenactivated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts. Bone 28: 45-53, 2001 https://doi.org/10.1016/S8756-3282(00)00413-0
  5. Chen CC, Sun YT, Chen JJ, Chang YJ. Tumor necrosis factoralpha- induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. Mol Pharmacol 59: 493-500, 2001 https://doi.org/10.1124/mol.59.3.493
  6. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983 https://doi.org/10.1093/nar/11.5.1475
  7. Fiebich BL, Mueksch B, Boehringer M, Hull M. Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogenactivated protein kinase and nuclear factor-kappaB. J Neurochem 75: 2020-2028, 2000 https://doi.org/10.1046/j.1471-4159.2000.0752020.x
  8. Flower RJ. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26: 33-67, 1974
  9. Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR. Induction of cyclooxygenase-2 by the activated MEKK1 \longrightarrow SEK1/MKK4 \longrightarrow p38 mitogen-activated protein kinase pathway. J Biol Chem 273: 12901-12908, 1998 https://doi.org/10.1074/jbc.273.21.12901
  10. Inoue H, Tanabe T. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys Res Commun 244: 143-148, 1998 https://doi.org/10.1006/bbrc.1998.8222
  11. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959, 1994 https://doi.org/10.1126/science.8052854
  12. Kozawa O, Tokuda H, Matsuno H., Uematsu T. Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts. J Cell Biochem 74: 479-485, 1999 https://doi.org/10.1002/(SICI)1097-4644(19990901)74:3<479::AID-JCB15>3.0.CO;2-9
  13. LaPointe MC, Isenovic E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33(1 Pt 2): 276-282, 1999 https://doi.org/10.1161/01.HYP.33.1.276
  14. Madge LA, Sierra-Honigmann MR, Pober JS. Apoptosis-inducing agents cause rapid shedding of tumor necrosis factor receptor 1 (TNFR1). A nonpharmacological explanation for inhibition of TNF-mediated activation. J. Biol Chem 274: 13643-13649, 1999 https://doi.org/10.1074/jbc.274.19.13643
  15. Naik SM, Shibagaki N, Li LJ, Quinlan KL, Paxton LL, Caughman SW. Interferon gamma-dependent induction of human intercellular adhesion molecule-1 gene expression involves activation of a distinct STAT protein complex. J Biol Chem 272: 1283- 1290, 1997 https://doi.org/10.1074/jbc.272.2.1283
  16. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 156: 3961-3969, 1996
  17. Pilbeam CC, Kawaguchi H, Hakeda Y, Voznesensky O, Alander CB, Raisz LG. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem 268: 25643-25649, 1993
  18. Rapuano BE, Bockman RS. Tumor necrosis factor-alpha stimulates phosphatidylinositol breakdown by phospholipase C to coordinately increase the levels of diacylglycerol, free arachidonic acid and prostaglandins in an osteoblast (MC3T3-E1) cell line. Biochim Biophys Acta 1091: 374-384, 1991 https://doi.org/10.1016/0167-4889(91)90203-A
  19. Sato K, Kasono K, Fujii Y, Kawakami M, Tsushima T, Shizume K. Tumor necrosis factor type alpha (cachectin) stimulates mouse osteoblast-like cells (MC3T3-E1) to produce macrophagecolony stimulating activity and prostaglandin E2. Biochem Biophys Res Commun 145: 323-329 1987 https://doi.org/10.1016/0006-291X(87)91324-6
  20. Saunders NA, Jetten AM. Control of growth regulatory and differentiation- specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1. J Biol Chem 269: 2016-2022, 1994
  21. Schwenger P, Skolnik EY, Vilcek J. Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate. J Biol Chem 271: 8089-8094, 1996 https://doi.org/10.1074/jbc.271.14.8089
  22. Schwenger P, Alpert D, Skolnik EY, Vilcek J. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol Cell Biol 18: 78-84, 1998 https://doi.org/10.1128/MCB.18.1.78
  23. Shapiro L, Dinarello CA. 1995. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 20: 12230-12234, 1995
  24. Shapiro L, Dinarello CA. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp Cell Res 231: 354- 362, 1997 https://doi.org/10.1006/excr.1997.3476
  25. Smith DD, Gowen M, Mundy GR. Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 120: 2494-2499, 1987 https://doi.org/10.1210/endo-120-6-2494
  26. Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 263: F181-191, 1992
  27. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271: 33157 -33160, 1996 https://doi.org/10.1074/jbc.271.52.33157
  28. Subbaramaiah K, Chung WJ, Dannenberg AJ. Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 273: 32943-32949, 1998 https://doi.org/10.1074/jbc.273.49.32943
  29. Suh N, Honda T, Finlay HJ, Barchowsky A, Williams C, Benoit NE, Xie QW, Nathan C, Gribble GW, Sporn MB. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res 58: 717-723, 1998
  30. Takahashi Y, Taketani Y, Endo T, Yamamoto S, Kumegawa M. Studies on the induction of cyclooxygenase isozymes by various prostagladins in mouse osteoblastic cell line with reference to signal transduction pathways. Biochim Biophys Acta 1212: 217 -224, 1994 https://doi.org/10.1016/0005-2760(94)90256-9
  31. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270: 31315-31320, 1995 https://doi.org/10.1074/jbc.270.52.31315
  32. Yanaga F, Abe M, Koga T, Hirata M. Signal transduction by tumor necrosis factor alpha is mediated through a guanine nucleotidebinding protein in osteoblast-like cell line, MC3T3-E1. J Biol Chem 267: 5114-5121, 1992
  33. Yin MJ, Yamamoto Y, Gaynor RB. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I (kappa) B kinasebeta. Nature 396: 77-80, 1998 https://doi.org/10.1038/23948
  34. Yosipovitch G, Yosipovitch Z, Harell D, Ashkenazi I, Erman A. Diurnal rhythm of prostanoid secretion from bone/marrow organ in the rat. Bone 17(1): 79-83, 1995 https://doi.org/10.1016/8756-3282(95)00141-Y
  35. Vietor I, Schwenger P, Li W, Schlessinger J, Vilcek J. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J Biol Chem 268: 18994-18999, 1993